169 related articles for article (PubMed ID: 16549639)
1. Relationship between homocysteine and mortality in chronic kidney disease.
Menon V; Sarnak MJ; Greene T; Wang X; Pereira AA; Beck GJ; Kusek JW; Selhub J; Collins AJ; Levey AS; Shlipak MG
Circulation; 2006 Mar; 113(12):1572-7. PubMed ID: 16549639
[TBL] [Abstract][Full Text] [Related]
2. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD.
Menon V; Greene T; Pereira AA; Wang X; Beck GJ; Kusek JW; Collins AJ; Levey AS; Sarnak MJ
Am J Kidney Dis; 2005 Sep; 46(3):455-63. PubMed ID: 16129207
[TBL] [Abstract][Full Text] [Related]
3. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
[TBL] [Abstract][Full Text] [Related]
4. Body mass index and mortality in CKD.
Madero M; Sarnak MJ; Wang X; Sceppa CC; Greene T; Beck GJ; Kusek JW; Collins AJ; Levey AS; Menon V
Am J Kidney Dis; 2007 Sep; 50(3):404-11. PubMed ID: 17720519
[TBL] [Abstract][Full Text] [Related]
5. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Bárány P; Heimbürger O; Vonesh EF; Lindholm B
Nephrol Dial Transplant; 2007 Jan; 22(1):209-17. PubMed ID: 16982634
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study.
Ninomiya T; Kiyohara Y; Kubo M; Tanizaki Y; Tanaka K; Okubo K; Nakamura H; Hata J; Oishi Y; Kato I; Hirakata H; Iida M
Am J Kidney Dis; 2004 Sep; 44(3):437-45. PubMed ID: 15332216
[TBL] [Abstract][Full Text] [Related]
7. Low total plasma homocysteine level in relation to malnutrition, inflammation, and outcome in hemodialysis patients.
Akgul A; Bilgic A; Sezer S; Arat Z; Ozdemir FN; Haberal M
J Ren Nutr; 2008 Jul; 18(4):338-46. PubMed ID: 18558298
[TBL] [Abstract][Full Text] [Related]
8. Renal dysfunction predicts long-term mortality in patients with lower extremity arterial disease.
Pasqualini L; Schillaci G; Pirro M; Vaudo G; Siepi D; Innocente S; Ciuffetti G; Mannarino E
J Intern Med; 2007 Dec; 262(6):668-77. PubMed ID: 17908164
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients.
Valli A; Carrero JJ; Qureshi AR; Garibotto G; Bárány P; Axelsson J; Lindholm B; Stenvinkel P; Anderstam B; Suliman ME
Clin Chim Acta; 2008 Sep; 395(1-2):106-10. PubMed ID: 18565329
[TBL] [Abstract][Full Text] [Related]
10. Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan.
Cheng TY; Wen SF; Astor BC; Tao XG; Samet JM; Wen CP
Am J Kidney Dis; 2008 Dec; 52(6):1051-60. PubMed ID: 18706747
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin and mortality in patients with chronic kidney disease.
Menon V; Li L; Wang X; Greene T; Balakrishnan V; Madero M; Pereira AA; Beck GJ; Kusek JW; Collins AJ; Levey AS; Sarnak MJ
J Am Soc Nephrol; 2006 Sep; 17(9):2599-606. PubMed ID: 16885405
[TBL] [Abstract][Full Text] [Related]
12. Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study.
Ninomiya T; Kiyohara Y; Tokuda Y; Doi Y; Arima H; Harada A; Ohashi Y; Ueshima H;
Circulation; 2008 Dec; 118(25):2694-701. PubMed ID: 19106392
[TBL] [Abstract][Full Text] [Related]
13. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population.
Meisinger C; Döring A; Löwel H;
Eur Heart J; 2006 May; 27(10):1245-50. PubMed ID: 16611670
[TBL] [Abstract][Full Text] [Related]
14. Relation of baseline presence and severity of renal disease to long-term mortality in persons with known stroke.
Ani C; Ovbiagele B
J Neurol Sci; 2010 Jan; 288(1-2):123-8. PubMed ID: 19853862
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.
Bostom AG; Carpenter MA; Kusek JW; Hunsicker LG; Pfeffer MA; Levey AS; Jacques PF; McKenney J;
Am Heart J; 2006 Sep; 152(3):448.e1-7. PubMed ID: 16923411
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Heinz J; Kropf S; Luley C; Dierkes J
Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
[TBL] [Abstract][Full Text] [Related]
17. The impact of circulating total homocysteine levels on long-term cardiovascular mortality in patients with acute coronary syndromes.
Foussas SG; Zairis MN; Makrygiannis SS; Manousakis SJ; Patsourakos NG; Adamopoulou EN; Beldekos DJ; Melidonis AI; Handanis SM; Manolis AJ; Hatzisavvas JJ; Argyrakis SK
Int J Cardiol; 2008 Mar; 124(3):312-8. PubMed ID: 17433477
[TBL] [Abstract][Full Text] [Related]
18. Total serum homocysteine, folate and vitamin B12 in a Greek school age population.
Papandreou D; Mavromichalis I; Makedou A; Rousso I; Arvanitidou M
Clin Nutr; 2006 Oct; 25(5):797-802. PubMed ID: 16690175
[TBL] [Abstract][Full Text] [Related]
19. Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes.
Foster MC; Hwang SJ; Larson MG; Parikh NI; Meigs JB; Vasan RS; Wang TJ; Levy D; Fox CS
Arch Intern Med; 2007 Jul; 167(13):1386-92. PubMed ID: 17620532
[TBL] [Abstract][Full Text] [Related]
20. All-cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate (eGFR): 10 years' data from the South Tees Diabetes Mortality study.
Nag S; Bilous R; Kelly W; Jones S; Roper N; Connolly V
Diabet Med; 2007 Jan; 24(1):10-7. PubMed ID: 17227319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
